DESTINY-Breast04DESTINY-Breast04资讯DESTINY-Breast04:T-DXd持久获益确立HER2低表达晚期乳腺癌治疗新标准ONCO前沿 | 2025-12-04FDA对HER2低表达乳腺癌治疗药物T-DXd的审批摘要拓麦精要 | 2023-08-24ASCO2023精要:ADC治疗BC的新进展(上)拓麦精要 | 2023-07-06